Cargando…
Morbidity and Mortality of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: National Cancer Institute, Mexico City, Mexico
Peritoneal carcinomatosis (PC) is generally considered a lethal disease, with a poor prognosis. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as a new approach for peritoneal surface disease. This study investigated the early experience with this comb...
Autores principales: | López-Basave, Horacio N., Morales-Vásquez, Flavia, Ruiz Molina, J. M., González-Enciso, Aaron, Ñamendys-Silva, Silvio A., Medina Castro, Juan M., Montalvo-Esquivel, Gonzalo, Herrera-Gómez, Angel, De la Garza Salazar, Jaime G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198603/ https://www.ncbi.nlm.nih.gov/pubmed/22091420 http://dx.doi.org/10.5402/2011/526384 |
Ejemplares similares
-
Organ dysfunction in critically ill cancer patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
por: ÑAMENDYS-SILVA, SILVIO A., et al.
Publicado: (2015) -
Intensive Care Unit Admission after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Is It Necessary?
por: López-Basave, Horacio N., et al.
Publicado: (2014) -
A contemporary analysis of morbidity and outcomes in cytoreduction/hyperthermic intraperitoneal chemoperfusion
por: Haslinger, Michelle, et al.
Publicado: (2013) -
Cytoreduction with hyperthermic intraperitoneal chemotherapy: An anaesthetic challenge
por: Murughan, Kavita, et al.
Publicado: (2014) -
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer
por: Gamboa, Adriana C., et al.
Publicado: (2019)